Arpita Dutt | TalkMarkets | Page 2

Arpita Dutt

Analyst at Zacks Research Pvt. Ltd.
Contributor's Links: Zacks Investment Research
Arpita has been an equity analyst at Zacks Investment Research since March, 2004.
Following: 12 Followers: 1915

All Contributions

Latest Posts
17 to 32 of 92 Posts
<<< 1 2 3 4 ... 6 >>>
What Is Ailing The Housing Industry? Three Factors At Play
Thursday, October 5, 2017 1:40 PM EDT
Recently released data on the housing industry has been disappointing and does not bode well for the sector with sales remaining under pressure.
In this article: BZH, KBH, PSMMY
Read
3 Biotech And Pharma Stocks With Key FDA Catalysts This October
Monday, October 2, 2017 10:16 AM EDT
The FDA, which approved 22 novel drugs last year, has given its approval to 34 drugs so far in 2017 including three in September.
In this article: FLXN, ALXN, PTCT Also: JNJ, TSRO, ACRX, AERI
Read
3 Heart Disease Focused Stocks To Buy Ahead Of World Heart Day
Tuesday, September 26, 2017 1:06 PM EDT
With World Heart Day coming up, let’s take a look at some well-positioned stocks in this segment of the market.
In this article: BEAT, EW, NVS Also: MRK, NVO, LLY
Read
4 Building Product Stocks In Focus On Hurricane Irma Aftermath
Thursday, September 14, 2017 11:46 AM EDT
Here are four building product stocks that will remain in focus as cleanup and rebuilding efforts pick pace.
In this article: OC, HD, LL, BLD
Read
Biotech Stock Roundup: Alexion To Cut Jobs, Streamline Operations, Kura Up On Cancer Data
Wednesday, September 13, 2017 11:21 AM EDT
There were quite a few major developments this week with Alexion Pharmaceuticals announcing a restructuring plan that will see the company cutting jobs and streamlining operations.
In this article: ALXN, REGN, ABBV, KURA, ICPT, SAGE, VRTX
Read
5 Top-Ranked Biotech Stocks To Buy Right Now
Monday, September 11, 2017 1:09 PM EDT
Picking biotech stocks can be a bit tricky given the “high risk - high returns” nature of the industry. Moreover, the estimate revision trend for the sector is not very encouraging.
In this article: REGN, ALXN, LGND, SGMO, FATE Also: KITE, GILD
Read
4 Biotech Stocks To Add To Your Portfolio Post Q2 Earnings
Tuesday, August 22, 2017 12:02 PM EDT
The second half of 2017 is expected to be catalyst rich for quite a few companies with data expected across a wide range of therapeutics areas.
In this article: ALXN, GILD, REGN, LGND Also: AMGN, NVS
Read
3 Buy-Ranked Stocks To Beat The Dip In Housing Starts
Thursday, August 17, 2017 1:25 PM EDT
Privately-owned housing starts declined 4.8% sequentially in July to a seasonally adjusted annual rate of 1,155,000. The numbers represent a 5.6% decline from the year-ago period as well.
In this article: KBH, NVR, TOL
Read
Forget Teva, Buy These 4 Drug Stocks Instead
Friday, August 11, 2017 1:17 PM EDT
It’s not been a good quarter for Israel-based generic drug maker, Teva Pharmaceutical Industries Limited. Teva missed on both second quarter earnings and revenues and lowered its outlook for 2017.
In this article: SNY, ALXN, REGN, GILD, TEVA
Read
4 Drug Stocks In Focus This World Hepatitis Day
Friday, July 28, 2017 10:45 AM EDT
The HCV market will continue to face challenges as more treatments enter the market resulting in increased competition and additional pricing pressure. In fact, HCV drugs have faced immense scrutiny due to their high prices.
In this article: GILD, MRK, ABBV, ENTA
Read
4 Sell-Ranked Drug Stocks To Avoid Ahead Of Q2 Earnings
Monday, July 17, 2017 11:35 AM EDT
Earnings season for the biotech and pharma sector kicks off this week with industry bellwether Johnson & Johnson reporting second quarter results tomorrow before the market opens.
In this article: VRX, FLXN, RXDX, ANIK Also: JNJ, NVS
Read
5 Pharma & Biotech Stocks That Could Be Big Winners In Q2 Earnings
Thursday, July 13, 2017 11:04 AM EDT
Drug stocks have bounced back this year with the Nasdaq Biotechnology Index and the NYSE ARCA Pharmaceutical Index gaining 18.6% and 10.8%, respectively, year-to-date (YTD).
In this article: MRK, GILD, LLY, CELG, SHPG
Read
Biotech Stock Roundup: EU Nod For Regeneron RA Drug, Portola Soars On FDA Nod
Thursday, June 29, 2017 9:44 AM EDT
Biotech stocks have been in the news recently with expectations remaining high that steps taken by the Trump administration to drive down drug prices will not be as draconian as previously expected.
In this article: PTLA, REGN, AVEO, GILD, ABBV, ALNY, BIIB
Read
Senate Unveils Its Version Of Trumpcare: Healthcare Stocks Up
Friday, June 23, 2017 12:00 PM EDT
Healthcare stocks rallied yesterday following the release of the Senate’s version of Trumpcare.
In this article: THC, HCA, MOH, UHS, UNH
Read
NVS Scores With Positive Data, Shire ADHD Drug Gets FDA Nod
Friday, June 23, 2017 10:00 AM EDT
This week’s highlights include positive data from Novartis while the FDA approved a couple of attention deficit hyperactive disorder (ADHD) drugs.
In this article: BMY, MRK, NVO, NVS, RHHBY, SHPG, NEOS
Read
3 Biotech Stocks That More Than Doubled Year To Date
Monday, June 19, 2017 2:24 PM EDT
Year-to-date (YTD), the Nasdaq Biotechnology Index is up 10.4% providing a glimmer of hope to biotech investors who saw the Index sliding 19.1% in 2016.
In this article: PBYI, SGMO, CYAD Also: PFE
Read
17 to 32 of 92 Posts
<<< 1 2 3 4 ... 6 >>>